Clinical Trials Browser

Uterine Cervical Neoplasms

NCT04445532 2023-07-07

Hepatobiliary Tumors Tissue Samples Acquisition

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Precancerous Conditions, Cholangiocarcinoma

NCT05832593 2023-04-27

Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.

Unknown

52 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04917263 2021-06-08

IMMUNOREACT2

Unknown

544 enrolled

Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

NCT04122131 2019-10-10

Fibrotic Focus in Breast Cancer

Unknown

250 enrolled

Breast

Breast Neoplasms

NCT03820921 2019-01-29

SUCCESS

Unknown

30 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT03078959 2017-03-14

Prognostic Value of PD-L1 in NSCLC

Unknown

350 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01004796 2016-02-29

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

Unknown

Breast

Breast Neoplasms

NCT02656134 2016-01-14

Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)

Unknown

55 enrolled

Gastrointestinal

Adenomatous Polyposis Coli

NCT00463034 2013-12-18

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer

Unknown

1,800 enrolled

Breast

Breast Neoplasms

NCT00898690 2013-12-18

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

Unknown

120 enrolled

Breast

Breast Neoplasms

NCT00897039 2013-09-20

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Unknown

60 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00899262 2013-08-26

Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

Unknown

300 enrolled

Thoracic

Lung Neoplasms, Tobacco Use Disorder

NCT00445783 2013-08-12

Study of Families With Melanoma

Unknown

3,700 enrolled

Dermatologic

Melanoma

NCT00897065 2013-07-10

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

Unknown

957 enrolled

Breast

Breast Neoplasms

NCT01150682 2011-04-29

Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

Unknown

865 enrolled

Gynecologic

Endometrial Neoplasms

NCT01074398 2010-02-24

Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182

Unknown

513 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Clinical Trials

EPIcol

Hepatobiliary Tumors Tissue Samples Acquisition

Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.

IMMUNOREACT2

Fibrotic Focus in Breast Cancer

SUCCESS

Prognostic Value of PD-L1 in NSCLC

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

Study of Families With Melanoma

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182